EASY BIO,Inc. (KOSDAQ:353810)
South Korea · Delayed Price · Currency is KRW 7,220.00
+360.00 (5.25%)
Mar 20, 2026, 3:30 PM KST
EASY BIO,Inc. Market Cap
EASY BIO,Inc. has a market cap or net worth of 238.85 billion as of March 20, 2026. Its market cap has increased by 46.21% in one year.
Market Cap
238.85B
Enterprise Value
375.66B
Revenue
465.24B
Ranking
n/a
PE Ratio
10.86
Stock Price
7,220.00
Market Cap Chart
Since June 5, 2020, EASY BIO,Inc.'s market cap has increased from 34.76B to 238.85B, an increase of 587.19%. That is a compound annual growth rate of 39.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 238.85B | 24.27% |
| Dec 30, 2025 | 192.21B | 37.78% |
| Dec 30, 2024 | 139.50B | 12.89% |
| Dec 28, 2023 | 123.58B | -10.06% |
| Dec 29, 2022 | 137.40B | -14.99% |
| Dec 30, 2021 | 161.64B | -23.75% |
| Dec 18, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 5, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BINEX | 400.33B |
| GC Cell | 379.44B |
| JETEMA, | 315.74B |
| Bioneer | 307.66B |
| HLB Therapeutics | 265.79B |
| Helixmith | 261.09B |
| Genexine | 211.94B |
| MedPacto | 198.45B |